9月11日，上海交通大学医学院附属瑞金医院王卫庆、王计秋团队在顶级期刊《Nature》上发文，研究发现大脑能够通过“脑-肠轴”通道直接调控肠道的脂肪吸收，同时确定了葛根提取物— 葛根素 ...

Fibrates are widely prescribed agonists of transcription factor peroxisome proliferator-activated receptor (PPAR)-α, and are used to treat patients with atherogenic dyslipidemia. These drugs ...

Table 1 Selected PPAR-targeted drugs in Phase II or III trials * Full size table Many research groups have “been fishing with the wrong bait” in trying to develop effective and safe anti ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...

在此次盛会上，东南大学附属中大医院李玲教授团队有15项最新研究成果将以口头报告（OP）和简短口头报告（SO）的形式呈现，充分彰显了我国中青年学者在糖尿病研究领域的前沿视角和蓬勃活力，受到国际医学界同行的广泛关注。

PPAR - Loving Living Local ...

2024年9月9日-13日，第60届欧洲糖尿病研究协会年会（EASD2024）在西班牙马德里举行。EASD年会是涵盖糖尿病临床诊疗与科学研究的国际顶级会议，全球科学家将共聚于此分享最新研究突破并学习交流经验，探讨内分泌与代谢性疾病诊治前沿进展。在此次 ...

The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects.

The European Commission (EC) has conditionally approved Ipsen’s Iqirvo (elafibranor) for the treatment of primary biliary ...

为更好地服务中国市场，USANA葆婴始终致力于本土化创新。这一过程中，公司深入了解中国消费者的健康需求与生活习惯，量身打造了一系列符合中国国情的健康产品与服务。从产品研发到市场推广，每一个环节都融入了对中国市场的深刻理解与尊重。这种本土化的创新策略，不仅让USANA葆婴的产品更加贴近中国消费者的实际需求，也为其在中国市场的长远发展奠定了坚实的基础。

A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...

Recruitment in NATiV3 clinical trial progresses with over 85% of the targeted number of patients enrolled in the main cohort and a statistical ...